63
Participants
Start Date
September 1, 2025
Primary Completion Date
September 30, 2026
Study Completion Date
December 31, 2026
ORAL-LYO-FMT
An oral capsule formulation of lyophilized fecal microbiota. Participants receive 7 capsules, three times per week (Monday, Wednesday, Friday), for either 4 or 7 weeks depending on treatment allocation. The product aims to restore healthy gut microbiota for treatment of IBS-D or prevention of rCDI.
Placebo
Double-coated oral capsules visually identical to ORAL-LYO-FMT but containing no active material. Participants receive 7 capsules, three times per week, for either 3 or 7 weeks depending on treatment allocation.
Lead Sponsor
PharmaPlanter Technologies Inc
NETWORK